These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25586243)

  • 21. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
    Edfeldt K; Hellman P; Westin G; Stalberg P
    BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains.
    Nieser M; Henopp T; Brix J; Stoß L; Sitek B; Naboulsi W; Anlauf M; Schlitter AM; Klöppel G; Gress T; Moll R; Bartsch DK; Heverhagen AE; Knoefel WT; Kaemmerer D; Haybaeck J; Fend F; Sperveslage J; Sipos B
    Neuroendocrinology; 2017; 104(3):302-312. PubMed ID: 27222126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.
    de Mestier L; Pasmant E; Fleury C; Brixi H; Sohier P; Féron T; Diebold MD; Clauser E; Cadiot G;
    Dig Liver Dis; 2017 Jan; 49(1):98-102. PubMed ID: 27825921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
    Lee HS; Chen M; Kim JH; Kim WH; Ahn S; Maeng K; Allegra CJ; Kaye FJ; Hochwald SN; Zajac-Kaye M
    Int J Cancer; 2014 Jul; 135(1):128-37. PubMed ID: 24347111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.
    Li SC; Khan M; Caplin M; Meyer T; Öberg K; Giandomenico V
    PLoS One; 2015; 10(5):e0125553. PubMed ID: 25942502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.
    Neklason DW; VanDerslice J; Curtin K; Cannon-Albright LA
    Endocr Relat Cancer; 2016 Feb; 23(2):93-100. PubMed ID: 26604321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors.
    Mäkinen N; Zhou M; Zhang Z; Kasai Y; Perez E; Kim GE; Thirlwell C; Nakakura E; Meyerson M
    Genome Med; 2022 Aug; 14(1):82. PubMed ID: 35922826
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Faisal FA; Murali S; Kaur H; Vidotto T; Guedes LB; Salles DC; Kothari V; Tosoian JJ; Han S; Hovelson DH; Hu K; Spratt DE; Baras AS; Tomlins SA; Schaeffer EM; Lotan TL
    Clin Cancer Res; 2020 Jun; 26(11):2595-2602. PubMed ID: 31969336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs).
    Perez K; Kulke MH; Chittenden A; Ukaegbu C; Astone K; Alexander H; Brais L; Zhang J; Garcia J; Esplin ED; Yang S; Da Silva A; Nowak JA; Yurgelun MB; Garber J; Syngal S; Chan J
    JCO Precis Oncol; 2021 Nov; 5():808-816. PubMed ID: 34994613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic alterations of CDKN1B are associated with small bowel neuroendocrine tumors.
    Maxwell JE; Sherman SK; Li G; Choi AB; Bellizzi AM; O'Dorisio TM; Howe JR
    Cancer Genet; 2015 Sep; ():. PubMed ID: 26603463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets.
    Andersson E; Arvidsson Y; Swärd C; Hofving T; Wängberg B; Kristiansson E; Nilsson O
    Mod Pathol; 2016 Jun; 29(6):616-29. PubMed ID: 26965582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
    Shi C; Gonzalez RS; Zhao Z; Koyama T; Cornish TC; Hande KR; Walker R; Sandler M; Berlin J; Liu EH
    Am J Clin Pathol; 2015 Mar; 143(3):398-404. PubMed ID: 25696798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.
    Haferlach C; Bacher U; Kohlmann A; Schindela S; Alpermann T; Kern W; Schnittger S; Haferlach T
    Haematologica; 2011 Jun; 96(6):829-36. PubMed ID: 21422114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
    Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
    Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The V109G polymorphism of the p27 gene CDKN1B indicates a worse outcome in node-negative breast cancer patients.
    Schöndorf T; Eisele L; Göhring UJ; Valter MM; Warm M; Mallmann P; Becker M; Fechteler R; Weisshaar MP; Hoopmann M
    Tumour Biol; 2004; 25(5-6):306-12. PubMed ID: 15627896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.
    Sherman SK; Maxwell JE; Carr JC; Wang D; Bellizzi AM; Sue O'Dorisio M; O'Dorisio TM; Howe JR
    Clin Exp Metastasis; 2014 Dec; 31(8):935-44. PubMed ID: 25241033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.
    Fotouhi O; Adel Fahmideh M; Kjellman M; Sulaiman L; Höög A; Zedenius J; Hashemi J; Larsson C
    Epigenetics; 2014 Jul; 9(7):987-97. PubMed ID: 24762809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
    Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
    Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.
    Görtz B; Roth J; Krähenmann A; de Krijger RR; Muletta-Feurer S; Rütimann K; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
    Am J Pathol; 1999 Feb; 154(2):429-36. PubMed ID: 10027401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.